z-logo
open-access-imgOpen Access
High levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 might be a biomarker of activity in pediatric patients with MOG-AD
Author(s) -
Anna Zhou,
Weihua Zhang,
Changhong Ren,
Ji Zhou,
Haoxiao Chang,
Xiaotun Ren
Publication year - 2022
Publication title -
frontiers in pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.96
H-Index - 36
ISSN - 2296-2360
DOI - 10.3389/fped.2022.908527
Subject(s) - medicine , cerebrospinal fluid , microglia , trem2 , biomarker , multiple sclerosis , myelin oligodendrocyte glycoprotein , neurodegeneration , immunology , neuroinflammation , ectodomain , receptor , pathology , disease , inflammation , biology , experimental autoimmune encephalomyelitis , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom